CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

dasiglucagon

Trade name: Zegalogue

Small moleculeapproved

Approved

Mar 22, 2021

Clinical trial activity

24 trials · 11 clinical orgs · 1 marketing orgs

Phase 1
5
Phase 2
17
Phase 3
11
Phase 4
0

Earliest trial started Dec 1, 2014 (NCT02367053)

Timeline

2010s

  1. Jan 1, 2014

    Zealand Pharma — Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2016

    Zealand Pharma — Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2017

    Zealand Pharma — Earliest Phase 3 Sponsor(trial)

2020s

  1. Mar 22, 2021

    Zealand Pharma — Earliest FDA Approval

  2. Mar 22, 2021

    Zealand Pharma — Marketing Organization

  3. Mar 22, 2021

    Zealand Pharma — NDA Secondary Org

  4. Mar 22, 2021

    Zealand Pharma — NDA Organization

Indications

Approved for

Studied for

Mechanism of action

Approval history

  • approvedMar 22, 2021

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Availability
Prescription Only

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • dasiglucagon
  • dasiglucagon

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06588504Phase 1Sep 10, 2024Novo Nordisk
NCT05454709Phase 2Jun 1, 2023Inreda Diabetic B.V., Medisch Spectrum Twente
NCT05378672Phase 3Jul 31, 2022Zealand Pharma
NCT04824872Phase 2Mar 31, 2022Zealand Pharma
NCT04836273Phase 2Aug 20, 2021University of Copenhagen, Zealand Pharma
NCT04764968Phase 2Apr 27, 2021Steno Diabetes Center Copenhagen
NCT04449692Phase 2Jul 2, 2020Steno Diabetes Center Copenhagen
NCT04192019Early Phase 1 (Phase 1)Apr 30, 2020University of Bern
NCT04172441Phase 2/Phase 3 (Phase 3)Nov 21, 2019Zealand Pharma
NCT03984370Phase 3Aug 26, 2019University of Copenhagen
NCT03840278Phase 2/Phase 3 (Phase 3)May 15, 2019Beta Bionics, Inc., Harvard University, Zealand Pharma
NCT03941236Phase 3May 1, 2019Zealand Pharma
NCT03895697Phase 3Mar 26, 2019Zealand Pharma
NCT03777176Phase 3Mar 4, 2019Zealand Pharma
NCT03735225Phase 1Nov 7, 2018Zealand Pharma
NCT03688711Phase 3Nov 1, 2018Zealand Pharma
NCT03667053Phase 3Sep 28, 2018Zealand Pharma
NCT03378635Phase 3Dec 7, 2017Zealand Pharma
NCT03216226Phase 3Jun 28, 2017Synteract, Inc., Zealand Pharma
NCT02916251Phase 2Dec 1, 2016Profil GmbH, Zealand Pharma
Showing 20 of 24 trials
Page 1 / 2

Organizations

Research & Development (11)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Zealand PharmaFor profit181632014
Profil GmbHFor profit4022014
Beta Bionics, Inc.For profit2022016
Harvard UniversityAcademic/Hospital2122016
Steno Diabetes Center CopenhagenAcademic/Hospital2212020
University of CopenhagenAcademic/Hospital2222019
Inreda Diabetic B.V.For profit1112023
Medisch Spectrum TwenteAcademic/Hospital1012023
Novo NordiskFor profit1112024
Synteract, Inc.For profit1012017
University of BernAcademic/Hospital1112020
11 organizations
Page 1 / 1

Marketing (3)

OrganizationOrg typeRelationshipDate
Zealand PharmaFor profitMKTGMar 22, 2021
Zealand PharmaFor profitNDA2Mar 22, 2021
Zealand PharmaFor profitNDAMar 22, 2021